Add-on Acquisition • Medical Products

Xenios AG Acquires XOR Labs

On February 22, 2016, Xenios AG acquired medical products company XOR Labs

Acquisition Context

This is Xenios AG’s 1st transaction in the Medical Products sector.
This is Xenios AG’s 1st transaction in Canada.
This is Xenios AG’s 1st transaction in Ontario.

Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free

M&A Deal Summary
Date	February 22, 2016
Target	XOR Labs
Sector	Medical Products
Buyer(s)	Xenios AG
Deal Type	Add-on Acquisition

Target Company

XOR Labs

Toronto, Ontario, Canada

XOR Labs, Inc. is a medical device company in the fields of organ transplantation and diseased organ treatment.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Buyer Overview 1

Buyer

Xenios AG

Heilbronn, Germany

Category	Company
Sector	Medical Products

DESCRIPTION

Xenios AG is a medical technology company involved in providing treatment of lung and cardiac failure.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Medical Products	1 of 1
Type: Add-on Acquisition	1 of 1
State: Ontario	1 of 1
Country: Canada	1 of 1
Year: 2016	1 of 1

Explore Related M&A Activity

Medical Products M&A - Add-on Acquisition M&A Deals - Ontario M&A - Canada M&A - 2016 M&A